Prestige Consumer Healthcare Inc 's ROA from the second quarter of 2026 to the second quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Prestige Consumer Healthcare Inc 's ROA in the second quarter of 2026?
Prestige Consumer Healthcare Inc achieved a return on average assets (ROA) of 7.87 % in its second quarter of 2026, this is above PBH's average return on assets of 6.4%.
Prestige Consumer Healthcare Inc s assets during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 89 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 446, from total ROA ranking in the first quarter of 2026 at 483.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) II. Quarter	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter
Y / Y Total Assets Change	37.17 %	33.13 %	2.71 %	4.96 %	3.78 %
Y / Y Net Income Change	-77.28 %	-38.01 %	-4.34 %	-23.14 %	-11.66 %
Net Income (TTM) in million	320	406	448	453	486
Return On Assets (TTM)	7.87 %	10.83 %	12.92 %	13.16 %	14.28 %
PBH's Total Ranking	# 446	# 483	# 383	# 345	# 354
Total Assets (TTM) in million	4,722	4,569	3,494	3,495	3,442
Seq. Total Assets Change	3.35 %	30.74 %	-0.01 %	1.52 %	0.31 %
Seq. Net Income Change	-62.65 %	-42.95 %	9.39 %	-2.55 %	1.92 %

PBH's 5 Years Annual ROA >> Back to PBH Management Effectiveness >> Compare PBH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 36
Sector	# 90
Overall	# 561

Return On Assets Statistics
High	Average	Low
14.95 %	6.4 %	-2.46 %
(Mar 31 2025)		(Jun 30 2023)

Financial Statements
Prestige Consumer Healthcare Inc 's Assets	$ 4,722 million	PBH's Balance sheet
Prestige Consumer Healthcare Inc 's Income	$ 25 million	Quarterly PBH's Income Statement
PBH's Income by Division		See PBH's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	2.71 %	2.53 %	-1.05 %	-8.63 %	7.04 %
Total Assets in million	3,494	3,402	3,318	3,354	3,671
Y / Y Net Income Change	-10.22 %	2.77 %	-	-	24.71 %
Net Income in million	448	499	485	-82	205
Annual Return On Assets	12.82 %	14.66 %	14.63 %	-2.45 %	5.6 %

PBH's 5 Years Annual ROA >> Back to PBH Management Effectiveness >> Compare PBH ROA to its Competitors

Comment on PBH's ROA in the fiscal year ending 2026

In the fiscal year 2026 Prestige Consumer Healthcare Inc 's ROA decreased compared to previous year to 12.82 %, due to deterioration of net income -10.22 % to $447.80 million, from $498.79 million a year ago, as PBH's assets were $3,494.31 million.

More Return On Assets Ratios
PBH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PBH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PBH's Competitors
Subscribers only: Roa for Prestige Consumer Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for PBH's Customers

You may also want to know
PBH's Roi	PBH's Inventory Turnover Ratio	PBH's Growth Rates	PBH's Dividend Comparisons
	PBH's Profitability Ratios	PBH's Asset Turnover Ratio	PBH's Dividend Growth
PBH's Roe	PBH's Valuation Ratios	PBH's Financial Strength Ratios	PBH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %

Date modified: 2026-11-06T12:56:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.